Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Tom Habraken has over 7 years of experience in the pharmaceutical industry in clinical development and pharmacology / pharmacokinetics and has a M.Sc. in Drug Innovation. He has been involved in in the design, planning, execution and reporting of multiples Ph1-Ph3 studies across diverse therapeutic areas such as Oncology, Immunology and CNS.
Tom is the Associate Group Leader Clinical Consultancy and Clinical Pharmacokinetic Consultant.
No articles found for this topic.
